Medical/Pharmaceuticals
First Medical Product in New Hybrid Light-Curable Adhesive Platform from Dymax
Offers Rapid Curing in Light or Darkness to a Wider Range of Substrates SINGAPORE, June 7, 2023 /PRNewswire/ -- Dymax, a leading manufacturer of rapid curing materials and equipment, is excited to announce the release of HLC-M-1000, the first product in its new Hybrid Light-Curable (HLC) series ...
2023-06-07 10:45
2353
Samyang Signs Partnership Agreement with Yxintent, China for Dermal Filler Lafullen®
* Yxintent will exclusively sell Lafullen® after conducting clinical trials and approval inChina, with Samyang supplying products worth KRW 100 billion over the next five years * Long-lasting biodegradable dermal filler with natural volume and long-lasting effects, proven safety and efficacy ...
2023-06-07 09:30
3529
Translumina bolsters its German presence with acquisition of Lamed GmbH
NEW DELHI and MUNICH, June 7, 2023 /PRNewswire/ -- Translumina, a global leader in interventional cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Munich-based Lamed GmbH. With this acquisition, Translumina has taken a step further...
2023-06-07 09:00
2905
Sunway Medical Centre is Malaysia's leading hospital in paediatrics, according to Best Specialized Hospitals Asia Pacific Newsweek rankings
The hospital also ranks highly in the areas of Oncology, Neurology and Cardiology SUBANG JAYA, Malaysia, June 7, 2023 /PRNewswire/ -- Sunway Medical Centre (SMC), Sunway City, the flagship quaternary hospital under the Sunway Healthcare Group, ranked the top for paediatrics inMalaysia, in the Be...
2023-06-07 08:30
2474
Colorcon, Inc. Invests in a New Film Coating Manufacturing Plant in Malaysia
Establishment of an eighth Colorcon film coating facility meets the expanding needs of the pharmaceutical and nutritional sectors inSoutheast Asia HARLEYSVILLE, Pa., June 6, 2023 /PRNewswire/ -- Colorcon, Inc. is proud to formally announce its investment in a new manufacturing plant in Johor Stat...
2023-06-06 20:00
3686
LiveSpo represents Vietnam to announce the world's first spore probiotics in nasal spray form at the BIO International Convention
BOSTON, June 6, 2023 /PRNewswire/ -- LiveSpo is the first representative from Vietnam to participate in the BIO International Convention, an exhibition showcasing breakthrough biotechnology solutions, held inBoston, USA. This demonstrates the remarkable development of the Vietnamese pharmaceutica...
2023-06-06 19:40
2252
Midea Healthcare Unveils New Solutions for Smart Healthcare Market
FOSHAN, China, June 6, 2023 /PRNewswire/ -- Midea Healthcare, as one of primarily business for Midea Group (000333.SZ), recently held a new product launch event in CMEF 2023 with its five medical industry consortia – Wandong (WDM), KUKA, Midea Biomedical, Swisslog Healthcare, and Midea Building ...
2023-06-06 16:10
2499
Biosyngen's Cell Therapy BRG01 Granted Orphan Drug Designation by the U.S. FDA for Treatment of Nasopharyngeal Cancer
SINGAPORE, June 6, 2023 /PRNewswire/ -- Jun. 1st, 2023, Biosyngen Pte. Ltd. (hereinafter as "Biosyngen") announced that the U.S. Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has granted to its application, for immune cell therapy BRG01for the treatment of nas...
2023-06-06 12:58
2485
Alphamab Oncology updated clinical research data for KN026 in Combination with KN046 in HER2-Positive Solid Tumors at the ASCO 2023 annual meeting
* As of November 10, 2022, 26 patients with HER2-positive unresectable or metastatic solid tumors (other than breast cancer and gastric/gastroesophageal junction cancer) were enrolled, 92.3% of whom had received ≥2L prior systemic therapy. The objective response rate (ORR) was 53.8% with 6.8 mo...
2023-06-06 09:06
2178
Telix to Present at Jefferies Healthcare Conference
MELBOURNE, Australia, June 6, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that DrChristian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies Healthcare Conference being held inNew York from June 7 to June 9, 2023...
2023-06-06 08:40
2025
Transcenta Presents Updated Data of Osemitamab (TST001) in Combination with CAPOX as a First-Line Treatment of G/GEJ Cancer at 2023 ASCO Annual Meeting
SUZHOU, China, June 6, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, has presented updated data of C...
2023-06-06 08:20
2374
Scientific Research Report Highlights Medit i700 wireless, Medit i700, and Medit i600 as Top Intraoral Scanners in Dentistry
* Dentists Worldwide Choose Medit i700 wireless and Medit i700 as Preferred Scanners * Medit Continues to Drive Innovation in Dental Technology with Award-Winning Scanners SEOUL, South Korea and LONG BEACH, Calif., June 6, 2023 /PRNewswire/ -- A recent transnational questionnaire study conduc...
2023-06-06 08:00
3321
Innovent Presents Phase 1 Clinical Data of IBI351 (KRASG12C Inhibitor) as Monotherapy for Metastatic Colorectal Cancer at the 2023 ASCO Annual Meeting
ROCKVILLE, Md. and SUZHOU, China, June 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2023-06-06 08:00
4399
Innovent and IASO Bio Updated Efficacy and Safety Clinical Data of Equecabtagene Autoleucel (BCMA CAR-T Cell Therapy) for Multiple Myeloma at the 2023 ASCO Annual Meeting
ROCKVILLE, Md. and SUZHOU, China, June 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2023-06-06 08:00
3918
ASCO 2023: RemeGen Exhibits Promising Results of Disitamab Vedotin in Bladder Cancer
YANTAI, China, June 5, 2023 /PRNewswire/ -- RemeGen Co., Ltd.
2023-06-05 21:26
2614
RemeGen Demonstrates Profitability to Successfully Receive Approval from the Hong Kong Stock Exchange to Upgrade Stock Short Name
The "B" marker is removed from the Company's stock short name
YANTAI, China, June 5, 2023 /PRNewswire/ -- RemeGen Co., Ltd.
2023-06-05 21:17
3394
Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure
Injectafer® (ferric carboxymaltose) is now the first and only intravenous (i.v.) iron replacement therapy in the U.S. indicated for improvement in exercise capacity in adult patients with symptomatic heart failure who have iron deficiency ST. GALLEN, Switzerland, June 5, 2023 /PRNewswire/ -- CSL...
2023-06-05 21:00
2861
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing
News Summary: * Integration of Sartorius' process scale multi-column chromatography with Waters' process analytical technology to provide robust analytical data for downstream biomanufacturing of mAbs, recombinant proteins, vaccines, and other biologics. * Integrated solution to deliver vita...
2023-06-05 20:00
2559
Prenetics Announces First Quarter 2023 Financial Results
HONG KONG, June 5, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial results for the first quarter endedMarch 31, 2023, along with recent business updates. First Quarter 2023 Fi...
2023-06-05 19:20
3178
Sirnaomics Reports Interim Results of STP705 Phase I Clinical Study for Medical Aesthetics Treatment in Adults Undergoing Abdominoplasty
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 5, 2023 /PRNewswire/ -- Sirnaomics Ltd.(the "Company", Stock Code: 2257.HK, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced the in...
2023-06-05 19:12
2684
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33
AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 295 media titles]
2024-04-12 15:14
Animated Life in Yunnan
[Picked up by 276 media titles]
2024-04-18 14:00
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 275 media titles]
2024-04-15 08:00
Most Read
AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
2024-04-12 15:14
6411
XCMG Machinery Launches Premium G2 Crane Brand
2024-04-12 14:39
6343
DEMAND AT ASIAN FACTORIES RISES AT STRONGEST RATE IN OVER 2 YEARS, IMPROVING NEAR-TERM GROWTH OUTLOOK FOR MANUFACTURING WORLDWIDE: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
2024-04-12 20:08
4529
Sephora appoints Xia Ding as Managing Director of Sephora Greater China
2024-04-15 17:33
3800